Kamal Hamed's most recent trade in Spero Therapeutics Inc was a trade of 239,731 Common Stock done . Disclosure was reported to the exchange on Feb. 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Spero Therapeutics Inc | Hamed Kamal | Chief Medical Officer | 01 Feb 2024 | 239,731 | 816,192 (4%) | 1% | 0 | Common Stock | ||
Spero Therapeutics Inc | Hamed Kamal | Chief Medical Officer | 01 Feb 2024 | 28,075 | 788,117 (4%) | 0% | 1.4 | 38,463 | Common Stock | |
Spero Therapeutics Inc | Kamal Hamed | Chief Medical Officer | 12 Jun 2023 | 140,000 | 615,957 (3%) | 0% | 0 | Common Stock | ||
Spero Therapeutics Inc | Kamal Hamed | Chief Medical Officer | 01 Feb 2023 | 265,957 | 475,957 (2%) | 1% | 0 | Common Stock | ||
Spero Therapeutics Inc | Kamal Hamed | Chief Medical Officer | 12 Sep 2022 | 210,000 | 210,000 (1%) | 1% | 0 | Common Stock |